“…Over the ensuing decades, a number of studies have tested our speculation of
PPI deficits across multiple brain disorders and confirmed that – in
addition to the reduction of PPI in schizophrenia populations, PPI is also impaired
in cohorts of patients with OCD (Ahmari et al,
2012; Hoenig et al, 2005; Kohl et al, 2015; Swerdlow et al, 1993b), TS (Buse et al, 2016; Castellan Baldan et al, 2014; Castellanos et al, 1996; Swerdlow et
al., 2001b; Zebardast et al,
2013), and HD (Munoz et al, 2003;
Swerdlow et al, 1995; Valls-Solé et al, 2004). In addition, PPI
deficits have been identified in other patient populations, including individuals
with nocturnal enuresis (Ornitz et al,
1992), Asperger’s syndrome (Howlin
and Murphy, 2002; McAlonan et al,
2002), 22q11 syndrome (Sobin et al,
2005), Kleinfelter syndrome (van Rijn et
al., 2011), fragile-X syndrome (Frankland
et al, 2004; Renoux et al, 2014;
Yuhas et al, 2011), and blepharospasm
(Gomez-Wong et al, 1998).…”